Cite

HARVARD Citation

    Geng, Q. et al. (2022). Effects of different doses of canagliflozin on blood pressure and lipids in patients with type 2 diabetes: a meta-analysis. Journal of hypertension. 40 (5), pp. 996-1001. [Online]. 
  
Back to record